Back to Search
Start Over
Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma.
- Source :
-
Blood [Blood] 2006 Apr 15; Vol. 107 (8), pp. 3415-6. - Publication Year :
- 2006
- Subjects :
- Bortezomib
Female
Graft vs Host Disease etiology
Graft vs Host Disease therapy
Humans
Male
Multiple Myeloma complications
Remission Induction
Transplantation, Homologous
Antineoplastic Agents administration & dosage
Boronic Acids administration & dosage
Immunosuppressive Agents administration & dosage
Lymphocyte Transfusion
Multiple Myeloma therapy
Pyrazines administration & dosage
Stem Cell Transplantation
Thalidomide administration & dosage
Subjects
Details
- Language :
- English
- ISSN :
- 0006-4971
- Volume :
- 107
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Blood
- Publication Type :
- Report
- Accession number :
- 16597603
- Full Text :
- https://doi.org/10.1182/blood-2005-11-4449